Related Experiment Videos
On the interaction between anthralin and mitochondria: a revision.
Archives of Dermatological Research
|January 1, 1986
Summary
Anthralin inhibits oxidative phosphorylation and ATP production by altering mitochondrial membranes, not by uncoupling. This finding impacts understanding of respiratory deficiency and psoriasis cellular metabolism.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Anthralin has been previously described as an uncoupler of oxidative phosphorylation.
- The mechanism of respiratory deficiency induced by anthralin in yeast strains is attributed to petite mutations.
Purpose of the Study:
- To elucidate the precise mechanism by which anthralin affects oxidative phosphorylation.
- To re-evaluate the role of anthralin in respiratory deficiency and its implications for cellular metabolism.
Main Methods:
- In vitro assays measuring oxygen consumption and ATP synthesis.
- Enzyme activity assays for isolated and membrane-bound ATPase.
- Electron spin resonance spectroscopy to assess mitochondrial membrane alterations.
Main Results:
- Anthralin inhibits ADP-stimulated oxygen consumption and reduces ATP synthesis, lowering mitochondrial ATP content.
- Anthralin does not affect isolated or membrane-bound ATPase activity and does not impact resting respiration.
- Experiments indicate anthralin alters mitochondrial membrane structure and function, suggesting a redox or free-radical mediated mechanism.
Conclusions:
- Anthralin is an inhibitor of oxidative phosphorylation, not an uncoupler.
- The previously proposed link between anthralin-induced respiratory deficiency and petite mutations in yeast requires reconsideration.
- Anthralin's inhibition of ATP production may limit cellular metabolism in conditions like psoriasis.